# CGM-Assisted Community Management for Type 2 Diabetes

Study · id `cardio:ct-nct07097415` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07097415](<https://clinicaltrials.gov/study/NCT07097415>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07097415

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 599 participants.

## Technical summary

Registry record NCT07097415. Non-randomized; no masking; primary purpose health services research. Start 2024-11-15 (actual); primary completion 2025-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 599 participants (enrolled count; ClinicalTrials.gov record NCT07097415, source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)
- Started: 2024-11-15 (actual) (ClinicalTrials.gov record NCT07097415, source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)
- Primary completion: 2025-11-30 (actual) (ClinicalTrials.gov record NCT07097415, source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)
- Completion: 2025-11-30 (actual) (ClinicalTrials.gov record NCT07097415, source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07097415, source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07097415-2026-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: CGM-Assisted Community Management for Type 2 Diabetes
- Condition: Type 2 Diabetes (T2DM)
- Intervention (Device): Yuwell Anytime CT3A Continuous Glucose Monitoring System
- Intervention (Other): CGM-Assisted Community Management Strategy
- Lead sponsor: Peking University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Peking University (`cardio:org-peking-university`)

## Provenance

Content hash: a7958b0bda5bbfb327820d046126cf938501d6ec2611abf3872a4ef40aede4e0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
